Aug 2026· Frontiers in Endocrinology· Vol 17· 1 citation· 31 references
Medicine
TL;DR
These findings support metabolic risk stratification in PCOS focused on obesity and insulin resistance rather than broader androgen-related markers.
Abstract
Introduction Polycystic ovary syndrome (PCOS) is frequently conceptualized as a hyperandrogenic disorder, yet cardiometabolic risk may be driven primarily by obesity and insulin resistance. We characterized glucose–insulin dynamics in women with PCOS and examined whether metabolic dysfunction was more closely associated with obesity status than with androgen-related parameters. Methods In this retrospective cross-sectional study, 71 women with PCOS underwent a standardized 3-hour oral glucose tolerance test (OGTT, 0–180 min) and were stratified by obesity status (BMI <30 kg/m², n=37; BMI ≥30 kg/m², n=34). OGTT-derived indices included the Matsuda index, HOMA-IR and AUCglucose(0–180). Associations were assessed using Pearson correlations and parsimonious multivariable linear regression models for log(Matsuda), log(HOMA-IR), and AUCglucose(0–180) including BMI, age and total testosterone as predictors. Results Obese women were older and had higher fasting glucose than non-obese women, whereas HbA1c was only numerically higher. During the OGTT, they showed higher glucose and insulin concentrations, lower insulin sensitivity, higher fasting insulin resistance, greater glucose exposure, and a higher insulin response relative to glucose exposure. PCOM prevalence, Rotterdam phenotype distribution, moderate-to-severe hirsutism and menstrual grades were similar between groups. Total testosterone and adrenal androgens were comparable. Across the parsimonious model, BMI was the only consistent independent predictor of log(Matsuda), log(HOMA-IR), and AUCglucose(0–180). Conclusions Within this PCOS cohort, metabolic impairment was more closely associated with BMI and obesity status than with the androgen-related parameters assessed. These findings support metabolic risk stratification in PCOS focused on obesity and insulin resistance rather than broader androgen-related markers.
Compared with controls, women with PCOS had higher body weight, body-mass index, waist circumference, waist circumference, triglyceride levels, insulin resistance-related parameters, triglyceride-glucose (TyG) Index, lipid accumulation product (LAP), and Atherogenic Index of Plasma (AIP), whereas high-density lipoprote...
Hatice Çalışkan Burgucu, Emel Yılmaz Kaya, Ayşen Yümlü et al.· Anatolian Current Medical Jo...· 0 citations
Hypogonadism in men with obesity is associated with abdominal obesity, hyperinsulinemia, and insulin resistance, and the HOMA-IR and Caro indices may be recommended as screening tools for detecting metabolic disturbances in this patient population.
K. Bairova, A. Mkrtumyan· Andrology and Genital Surger...· 0 citations
Background and Objectives: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder characterized by distinct phenotypic presentations. This study aimed to compare androgenic and metabolic characteristics across Rotterdam-defined PCOS phenotypes, with particular emphasis on insulin resistanc...
Karolin Ohanoglu Cetinel, Ahmet Cinar, Can Tercan et al.· Journal of Clinical Medicine· 0 citations
Endothelial dysfunction has been reported in polyendocrine metabolic ovarian syndrome (PMOS) and is associated with obesity. We hypothesised that circulating biomarkers of endothelial dysfunction would not differ between non-obese women with PMOS and age- and BMI-matched controls in the absence of major between-group d...
Manjula Nandakumar, Sana Waris, T. Sathyapalan et al.· International Journal of Mol...· 0 citations
Childhood obesity is associated with significant hormonal and metabolic alterations, suggesting early endocrine adaptations that may have metabolic implications, and findings highlight need for early identification and intervention to prevent potential long-term cardiometabolic risks associated with pediatric-onset obe...
Rakhi Jain, P. Upadhyay· International Journal of Con...· 0 citations
In this multicenter cohort, Rotterdam phenotypes failed to discriminate metabolic risk, whereas BMI-based stratification proved more informative in identifying cardiometabolic complications.
A. Gambineri, S. Federici, E. Maseroli et al.· Journal of Endocrinological...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.